Search Results

WY-14643 (Pirinixic Acid) 250mg  | 98.87%

APEXBIO TECHNOLOGY LLC

PPARα agonist,selective and highly potent Metabolism|PPAR

More Information Supplier Page

×

WY-14643 (Pirinixic Acid)

WY-14643 (Pirinixic Acid) 50mg  | 98.87%

APEXBIO TECHNOLOGY LLC

PPARα agonist,selective and highly potent Metabolism|PPAR

More Information Supplier Page

×

WY-14643 (Pirinixic Acid)

WY-14643 (Pirinixic Acid) 10mM (in 1mL DMSO)  | 98.87%

APEXBIO TECHNOLOGY LLC

PPARα agonist,selective and highly potent Metabolism|PPAR

More Information Supplier Page

×

WY-14643 (Pirinixic Acid)

Rosiglitazone 200mg  | 98.05%

APEXBIO TECHNOLOGY LLC

Potent PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone

GSK3787 10mg  | 99.49%

APEXBIO TECHNOLOGY LLC

PPARβ/δ antagonist,novel and irreversible Metabolism|PPAR

More Information Supplier Page

×

GSK3787

GSK3787 50mg  | 99.49%

APEXBIO TECHNOLOGY LLC

PPARβ/δ antagonist,novel and irreversible Metabolism|PPAR

More Information Supplier Page

×

GSK3787

Rosiglitazone 10mM (in 1mL DMSO)  | 98.05%

APEXBIO TECHNOLOGY LLC

Potent PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone

Rosiglitazone 25mg  | 98.05%

APEXBIO TECHNOLOGY LLC

Potent PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone

Rosiglitazone 100mg  | 98.05%

APEXBIO TECHNOLOGY LLC

Potent PPARγ agonist Metabolism|PPAR

More Information Supplier Page

×

Rosiglitazone

GSK3787 10mM (in 1mL DMSO)  | 99.49%

APEXBIO TECHNOLOGY LLC

PPARβ/δ antagonist,novel and irreversible Metabolism|PPAR

More Information Supplier Page

×

GSK3787